NRC National Research Corporation - Common Stock
Über National Research Corporation - Common Stock Unternehmensübersicht von Wikipedia
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
Mehr lesen
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
History
National Research Corporation was established in 1981 to provide performance measurement tools and insights for the healthcare industry.
In 1994, the Picker Institute was founded and began development of the Qualisys technology the following year. In 1998, National Research Corporation acquired Healthcare Research Systems, Inc., expanding its offerings in patient experience measurement.
In 2001, the company purchased the Picker Institute's healthcare survey business, enhancing its market presence in patient-centered research. Expansion continued in 2003 with the acquisition of Smaller World Communications, based in Canada.
The company entered the health risk assessment sector in 2005 through the acquisition of Geriatric Health Systems LLC. In 2006, it acquired TGI Group LLC, which led to the creation of The Governance Institute, a resource for healthcare governance education and research.
In 2009, National Research Corporation acquired My InnerView, a firm recognized for its long-term care quality and satisfaction surveys. This was followed in 2010 by the acquisition of OCS HomeCare, a provider of clinical and outcomes analytics for home health and hospice care.
In 2014, the company acquired Digital Assent, the first software platform to enable healthcare organizations to publish physician star ratings based on patient experience data.
In 2016, National Research Corporation rebranded as NRC Health, reflecting a broader commitment to human-centered care and consumer insights.
On February 11, 2020, NRC Health experienced a cyberattack that resulted in the temporary shutdown of its operations and raised concerns about the security of patient data maintained on behalf of its healthcare clients.
Awards
NRC Health is associated with several healthcare recognition programs, including the Consumer Choice Award, the AHCA/NCAL National Quality Award, and Excellence in Action. These programs acknowledge hospitals and long-term care providers based on performance metrics related to patient and resident satisfaction.
In 2010, the company was approved by the Centers for Medicare and Medicaid Services (CMS) as a vendor for the Home Health Consumer Assessment of Healthcare Providers and Systems (HHCAHPS) survey program.
In 2012 and 2013, Modern Healthcare identified NRC Health as the largest patient satisfaction measurement firm in the United States.
Products and services
Products and solutions provided by NRC Health follows the "Eight Dimensions of Patient-Centered Care" philosophy.
Under this strategy, the company provides:
Patient & Family Experience
Resident & Family Experience
Employee Engagement
Physician Engagement
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program
Market Insights
Healthcare Analytics
Clinical & Outcomes Analytics
Health Risk Assessments
Patient Outreach Programs
Integrated Solutions
The Institutes
CAHPS is a survey system, including HCAHPS, CGCAHPS, HHCAHPS, NHCAHPS, Pediatric HCAHPS, and ICHCAHPS.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
NRC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
NRC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 26. Juni 2026 | $0,1600 |
| 27. März 2026 | $0,1600 |
| 26. Dezember 2025 | $0,1600 |
| 26. September 2025 | $0,1200 |
| 27. Juni 2025 | $0,1200 |
| 28. März 2025 | $0,1200 |
| 27. Dezember 2024 | $0,1200 |
| 27. September 2024 | $0,1200 |
| 28. Juni 2024 | $0,1200 |
| 27. März 2024 | $0,1200 |
| 28. Dezember 2023 | $0,1200 |
| 28. September 2023 | $0,1200 |
| 15. September 2023 | $1,0000 |
| 29. Juni 2023 | $0,1200 |
| 30. März 2023 | $0,1200 |
| 29. Dezember 2022 | $0,1200 |
| 29. September 2022 | $0,2400 |
| 29. Juni 2022 | $0,2400 |
| 30. März 2022 | $0,2400 |
| 29. Dezember 2021 | $0,1200 |
NRC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 1 20,0%
- Kauf 3 60,0%
- Halten 1 20,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
1 Analysten · 2026-08-16Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.31 | $0.14 | 0.17% |
| 31. März 2026 | $0.21 | — | — |
| 31. Dezember 2025 | $0.16 | — | — |
| 30. September 2025 | $0.23 | — | — |
| 30. Juni 2019 | $0.29 | $0.26 | 0.03% |
| 31. März 2019 | $0.32 | $0.31 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NRC | — | 0.4 | -4.0% | — | — | — |
| VMD | $282M | 20.1 | 20.5% | 5.5% | 10.9% | 57.5% |
| SBC | — | — | — | — | — | — |
| BDSX | $56M | -1.5 | 24.1% | -39.9% | 5315.0% | — |
| AIRS | $128M | -10.4 | -15.8% | -7.7% | -13.1% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| SG&A Expense | $55M | $45M | $47M | $43M | $39M | $34M | $33M | $31M | $30M | $28M | $27M | $25M | |
| Operating Expenses | $115M | $108M | $109M | $105M | $98M | $91M | $85M | $84M | $83M | $78M | $76M | $71M | |
| Operating Income | $23M | $35M | $40M | $47M | $50M | $43M | $43M | $35M | $34M | $31M | $26M | $28M | |
| Interest Expense | · | $3M | $862.0K | $1M | $2M | $2M | $2M | $2M | $82.0K | $190.0K | $220.0K | $305.0K | |
| Interest Income | $111.0K | $125.0K | $820.0K | $168.0K | $14.0K | $18.0K | $37.0K | $62.0K | $96.0K | $47.0K | $60.0K | $83.0K | |
| Other Non-op | $-95.0K | $-34.0K | $-41.0K | $-118.0K | $4.0K | $585.0K | $-462.0K | $885.0K | $50.0K | $302.0K | $1M | $18.0K | |
| Pretax Income | $18M | $33M | $40M | $43M | $49M | $41M | $41M | $35M | $34M | $31M | $27M | $28M | |
| Income Tax | $6M | $8M | $9M | $11M | $11M | $4M | $8M | $5M | $11M | $11M | $10M | $10M | |
| Net Income | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| EPS (Basic) | $50.00 | $1.05 | $1.26 | $1.28 | $1.47 | $1.48 | $1.30 | · | · | · | · | · | |
| EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | · | · | · | · | · | |
| Shares (Basic) | 22,383,000 | 23,703,000 | 24,540,000 | 24,922,000 | 25,422,000 | 25,170,000 | 24,809,000 | · | · | · | · | · | |
| Shares (Diluted) | 22,396,000 | 23,743,000 | 24,673,000 | 25,052,000 | 25,640,000 | 25,696,000 | 25,653,000 | · | · | · | · | · | |
| EBITDA | · | $35M | $40M | $47M | $50M | · | $43M | $35M | $34M | $31M | $26M | $32M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $7M | $25M | $54M | $35M | $14M | $13M | $35M | $33M | $42M | $40M | |
| Receivables | $11M | $11M | $12M | $14M | $14M | $14M | $12M | $12M | $15M | $11M | $10M | $8M | |
| Prepaid Expense | $4M | $3M | $4M | $2M | $4M | $3M | $2M | $3M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $520.0K | $692.0K | $940.0K | $1M | $982.0K | $2M | $2M | $224.0K | $35.0K | $35.0K | $34.0K | $994.0K | |
| Current Assets | $20M | $20M | $24M | $44M | $74M | $54M | $29M | $28M | $52M | $47M | $55M | $53M | |
| PP&E (Net) | · | $38M | $28M | $17M | $12M | $12M | $14M | $14M | $12M | $12M | $11M | $12M | |
| PP&E (Gross) | · | $74M | $64M | $51M | $46M | $43M | $42M | $45M | $40M | $38M | $35M | $35M | |
| Accum. Depreciation | · | $35M | $36M | $34M | $33M | $31M | $29M | $31M | $28M | $26M | $23M | $23M | |
| Goodwill | $66M | $66M | $62M | $62M | $62M | $57M | $58M | $58M | $58M | $58M | $58M | $58M | |
| Intangibles | $2M | $3M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $4M | $5M | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $768.0K | $293.0K | $234.0K | |
| Total Assets | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $613.0K | $593.0K | $765.0K | $614.0K | $830.0K | |
| Accrued Liabilities | $3M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Short-term Debt | $4M | $5M | $7M | $4M | $4M | $4M | $4M | $4M | $1M | $3M | $2M | $2M | |
| Current Liabilities | $37M | $36M | $36M | $33M | $40M | $32M | $38M | $47M | $32M | $32M | $44M | $28M | |
| Capital Leases | $744.0K | $1M | $2M | · | · | · | · | $676.0K | $87.0K | $110.0K | $103.0K | $167.0K | |
| Deferred Tax | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $6M | $4M | $5M | $6M | $7M | |
| Other Non-current Liabilities | $3M | $4M | $4M | $2M | $3M | $4M | $2M | $1M | $935.0K | $777.0K | $575.0K | $541.0K | |
| Total Liabilities | $121M | $101M | $73M | $58M | $72M | $69M | $78M | $89M | $37M | $38M | $54M | $42M | |
| Long-term Debt | $79M | · | $37M | $22M | $27M | $31M | $34M | $38M | $1M | $4M | $6M | $8M | |
| Total Debt | · | $63M | $7M | $4M | $4M | · | $34M | $38M | $2M | $6M | $8M | $10M | |
| Common Stock | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $30.0K | $30.0K | $26.0K | · | · | · | |
| Retained Earnings | $-17M | $-17M | $-31M | $-25M | $-36M | $-61M | $-93M | $-106M | $78M | $72M | $65M | $74M | |
| Treasury Stock | $153M | $132M | $99M | $78M | $50M | $44M | $34M | $29M | $37M | $33M | $32M | $30M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-3M | $-3M | $-773.0K | |
| Stockholders' Equity | $14M | $31M | $49M | $72M | $85M | $64M | $33M | $19M | $90M | $83M | $74M | $88M | |
| Liabilities + Equity | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Shares Outstanding | 22,637,252 | 23,083,116 | 24,219,887 | 24,628,173 | 25,361,409 | 25,390,968 | 24,947,500 | 24,800,796 | 20,936,703 | · | · | · |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $6M | $6M | · | · | · | $6M | $5M | $5M | $4M | $4M | $4M | |
| Stock-based Comp | $3M | $284.0K | $935.0K | $1M | $623.0K | $680.0K | $1M | $2M | $2M | $2M | $1M | $742.0K | |
| Deferred Tax | $2M | $-664.0K | $-1M | $-2M | $-277.0K | $-134.0K | $1M | $1M | $-684.0K | $798.0K | $-1M | $107.0K | |
| Amort. of Intangibles | $389.0K | $264.0K | $140.0K | $180.0K | $320.0K | $318.0K | $374.0K | $662.0K | $610.0K | $654.0K | $995.0K | $876.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $26M | $35M | $38M | $36M | $46M | $41M | $41M | $40M | $28M | $27M | $22M | $26M | |
| CapEx | $11M | $15M | $16M | $10M | $6M | $4M | $5M | $6M | $5M | $4M | $3M | $2M | |
| Investing Cash Flow | $-11M | $-20M | $-16M | $-10M | $-9M | $-4M | $-5M | $-6M | $-6M | $-4M | $-1M | $-6M | |
| Stock Repurchased | $20M | $31M | $19M | $28M | $4M | · | · | · | · | · | $2M | · | |
| Net Stock Activity | · | $-31M | $-19M | $-28M | $-4M | · | · | · | · | · | $-2M | · | |
| Dividends Paid | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · | |
| Financing Cash Flow | $-16M | $-17M | $-41M | $-56M | $-18M | $-16M | $-36M | $-54M | $-21M | $-33M | $-17M | $-2M | |
| Net Change in Cash | $-94.0K | $-2M | $-18M | $-29M | $20M | $21M | $526.0K | $-22M | $2M | $-9M | $2M | $18M | |
| Taxes Paid | · | $8M | $9M | $12M | $11M | $5M | $7M | $3M | $13M | $10M | $9M | · | |
| Free Cash Flow | · | $19M | $22M | $26M | $41M | · | $36M | $34M | $24M | $23M | $19M | $24M | |
| Levered FCF | · | $17M | $22M | $26M | $40M | · | $35M | $33M | $23M | $23M | $19M | $24M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | |
| Net Margin | · | 17.3% | 20.8% | 21.0% | 25.3% | · | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | |
| Pretax Margin | · | 22.9% | 26.9% | 28.2% | 32.9% | · | 31.7% | 29.0% | 29.2% | 28.7% | 26.7% | 28.4% | |
| EBITDA Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 32.5% | |
| ROA | · | 19.4% | 24.5% | 22.1% | 25.8% | · | 29.6% | 25.5% | 18.5% | 16.5% | 13.6% | 15.1% | |
| ROE | · | 75.2% | 58.0% | 45.5% | 44.5% | · | 104.8% | 122.1% | 26.6% | 26.1% | 21.7% | 22.8% | |
| ROIC | · | 28.4% | 55.2% | 45.2% | 43.2% | · | 51.3% | 53.6% | 24.8% | 22.9% | 20.7% | 18.6% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.5 | 0.7 | 1.3 | 1.8 | · | 0.8 | 0.6 | 1.6 | 1.5 | 1.3 | 1.9 | |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 | · | 0.7 | 0.5 | 1.5 | 1.4 | 1.2 | 1.7 | |
| Debt / Equity | · | 2.0 | 0.1 | 0.1 | 0.1 | · | 1.0 | 2.0 | 0.0 | 0.1 | 0.1 | 0.1 | |
| LT Debt / Equity | · | 1.9 | · | · | · | · | 0.9 | 1.8 | · | 0.0 | 0.0 | 0.1 | |
| Interest Coverage | · | 13.6 | 46.5 | 38.5 | 30.2 | · | 20.6 | 23.3 | 417.3 | 164.2 | 120.2 | 92.8 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.1 | 1.0 | · | 1.2 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | |
| Receivables Turnover | · | 12.2 | 11.1 | 10.8 | 10.7 | · | 10.9 | 9.0 | 9.7 | 10.6 | 11.4 | 10.3 |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.0% | -3.7% | -2.0% | 2.4% | 11.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -3.2% | -1.1% | 3.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.61% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4707.7% | -16.8% | -1.6% | -13.0% | 0.69% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 240.2% | -10.7% | -4.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -53.2% | -20.0% | -2.6% | -15.1% | 0.55% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -28.5% | -12.9% | -6.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -20.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 0.86% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| Net Income TTM | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| Market Cap | · | $407M | $958M | $919M | $1.05B | · | $1.65B | $946M | · | · | · | · | |
| Enterprise Value | · | $466M | $959M | $898M | $1.00B | · | $1.67B | $971M | · | · | · | · | |
| P/E | 0.4 | 17.0 | 31.6 | 29.4 | 28.4 | 29.5 | 52.3 | 16.7 | 16.4 | 8.3 | 7.0 | 6.1 | |
| P/S | · | 2.8 | 6.4 | 6.1 | 7.1 | · | 12.9 | 7.9 | · | · | · | · | |
| P/B | · | 13.0 | 19.6 | 12.8 | 12.3 | · | 50.0 | 49.6 | · | · | · | · | |
| P / Tangible Book | · | · | · | 104.3 | 48.0 | 192.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | 11.8 | 25.1 | 25.3 | 22.7 | · | 40.2 | 23.7 | · | · | · | · | |
| P / FCF | · | 21.2 | 42.9 | 34.8 | 25.8 | · | 45.4 | 27.9 | · | · | · | · | |
| EV / EBITDA | · | 13.2 | 23.9 | 19.3 | 20.0 | · | 38.7 | 27.5 | · | · | · | · | |
| EV / FCF | · | 24.3 | 42.9 | 34.0 | 24.6 | · | 45.9 | 28.7 | · | · | · | · | |
| EV / Revenue | · | 3.3 | 6.5 | 5.9 | 6.8 | · | 13.0 | 8.1 | · | · | · | · | |
| Dividend Yield | · | 2.8% | 3.8% | 2.3% | 0.87% | · | 1.9% | 1.8% | · | · | · | · | |
| Earnings Yield | 266.4% | 5.9% | 3.2% | 3.4% | 3.5% | 3.4% | 1.9% | 6.0% | 6.1% | 12.0% | 14.2% | 16.3% | |
| Payout Ratio | · | 46.2% | 117.4% | 65.9% | 24.4% | · | 96.6% | 56.1% | 73.5% | 139.2% | 57.1% | · | |
| Annual Payout | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35M | $35M | $35M | $35M | $34M | $34M | $37M | $36M | $35M | $35M | $38M | $38M | $36M | $36M | $38M | $38M | |
| SG&A Expense | $23M | $13M | $14M | $12M | $18M | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $12M | $11M | $11M | |
| Operating Expenses | $39M | $29M | $31M | $27M | $32M | $25M | $27M | $28M | $26M | $27M | $26M | $28M | $27M | $27M | $26M | $27M | |
| Operating Income | $-3M | $6M | $5M | $8M | $2M | $9M | $10M | $8M | $9M | $9M | $12M | $10M | $9M | $9M | $12M | $11M | |
| Interest Expense | · | · | · | $1M | $1M | $899.0K | · | $706.0K | $555.0K | $605.0K | · | $160.0K | $192.0K | $241.0K | $286.0K | $288.0K | |
| Interest Income | $20.0K | $35.0K | $30.0K | $41.0K | $21.0K | $19.0K | $22.0K | $34.0K | $25.0K | $44.0K | $41.0K | $256.0K | $273.0K | $250.0K | $134.0K | $15.0K | |
| Other Non-op | $2.0K | $30.0K | $-61.0K | $-45.0K | $4.0K | $7.0K | $-6.0K | $-12.0K | $-11.0K | $-5.0K | $-13.0K | $-12.0K | $-2.0K | $-14.0K | $-49.0K | $11.0K | |
| Pretax Income | $-5M | $4M | $3M | $6M | $581.0K | $8M | $9M | $7M | $8M | $8M | $11M | $10M | $9M | $9M | $9M | $11M | |
| Income Tax | $-1M | $1M | $1M | $2M | $687.0K | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Net Income | $-3M | $3M | $2M | $4M | $-106.0K | $6M | $7M | $6M | $6M | $6M | $9M | $8M | $7M | $7M | $7M | $8M | |
| EPS (Basic) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.28 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.30 | $0.28 | $0.27 | $0.34 | |
| EPS (Diluted) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.27 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.29 | $0.28 | $0.27 | $0.33 | |
| Shares (Basic) | 22,009,000 | 21,799,000 | -45,377,000 | 22,130,000 | 22,658,000 | 22,972,000 | -47,757,000 | 23,721,000 | 23,871,000 | 23,868,000 | -49,183,000 | 24,560,000 | 24,578,000 | 24,585,000 | -50,128,000 | 24,716,000 | |
| Shares (Diluted) | 22,009,000 | 21,911,000 | -45,366,000 | 22,130,000 | 22,658,000 | 22,974,000 | -47,880,000 | 23,745,000 | 23,915,000 | 23,963,000 | -49,476,000 | 24,695,000 | 24,716,000 | 24,738,000 | -50,396,000 | 24,847,000 | |
| EBITDA | $-3M | $6M | · | $8M | $2M | $9M | · | $8M | $9M | $9M | · | $10M | $9M | $9M | · | $11M |
Bilanz 28
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $4M | $2M | $5M | $3M | $4M | $3M | $485.0K | $2M | · | $4M | $22M | $24M | · | $28M | |
| Receivables | $9M | $11M | $11M | $13M | $12M | $11M | $11M | $11M | $10M | $11M | · | $14M | $12M | $14M | · | $15M | |
| Prepaid Expense | $5M | $6M | $4M | $4M | $5M | $6M | $3M | $5M | $5M | $6M | · | $6M | $6M | $6M | · | $4M | |
| Other Current Assets | $431.0K | $461.0K | $520.0K | $973.0K | $2M | $588.0K | $692.0K | $664.0K | $1M | $777.0K | · | $369.0K | $834.0K | $1M | · | $1M | |
| Current Assets | $23M | $20M | $20M | $20M | $25M | $20M | $20M | $21M | $17M | $20M | · | $25M | $41M | $45M | · | $49M | |
| PP&E (Net) | · | · | · | $41M | $42M | $40M | · | $36M | $34M | $32M | · | $26M | $23M | $19M | · | $16M | |
| PP&E (Gross) | · | · | · | $82M | $81M | $77M | · | $76M | $72M | $69M | · | $63M | $59M | $54M | · | $52M | |
| Accum. Depreciation | · | · | · | $41M | $38M | $37M | · | $40M | $39M | $37M | · | $37M | $36M | $35M | · | $36M | |
| Goodwill | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $62M | $62M | $62M | $62M | $62M | $62M | · | $62M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $3M | $4M | $6M | $2M | $3M | · | $4M | $5M | $4M | · | $3M | |
| Total Assets | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $3M | $1M | $2M | · | $1M | $2M | $1M | · | $1M | |
| Accrued Liabilities | $4M | $3M | $3M | $4M | $6M | $5M | $5M | $6M | $5M | $6M | · | $5M | $4M | $4M | · | $5M | |
| Short-term Debt | $4M | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $8M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Liabilities | $35M | $38M | $37M | $39M | $36M | $38M | $36M | $44M | $46M | $49M | · | $41M | $34M | $36M | · | $41M | |
| Capital Leases | · | · | $744.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $6M | $6M | $6M | $3M | $4M | $5M | $4M | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | · | $3M | $2M | $2M | · | $2M | |
| Total Liabilities | $130M | $121M | $121M | $121M | $120M | $106M | $101M | $97M | $79M | $84M | · | $62M | $56M | $60M | · | $67M | |
| Long-term Debt | $90M | · | · | · | · | · | · | $49M | $33M | $35M | · | $19M | $20M | $21M | · | $23M | |
| Total Debt | $94M | $78M | · | $80M | $81M | $62M | · | $49M | $33M | $35M | · | $5M | $5M | $5M | · | $4M | |
| Common Stock | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | · | $31.0K | $31.0K | $31.0K | · | $31.0K | |
| Retained Earnings | $-25M | $-18M | $-17M | $-15M | $-17M | $-14M | $-17M | $-21M | $-24M | $-27M | · | $-36M | $-17M | $-21M | · | $-29M | |
| Treasury Stock | $162M | $154M | $153M | $152M | $143M | $137M | $132M | $125M | $116M | $116M | · | $82M | $82M | $80M | · | $76M | |
| Stockholders' Equity | $7M | $13M | $14M | $14M | $21M | $30M | $31M | $35M | $40M | $37M | $49M | $58M | $78M | $75M | $72M | $68M | |
| Liabilities + Equity | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Shares Outstanding | 22,139,315 | 22,536,696 | 22,637,252 | 22,657,421 | 23,103,685 | 22,785,421 | 23,083,116 | 23,476,040 | 23,871,257 | 23,877,315 | · | 24,562,068 | 24,567,092 | 24,599,815 | · | 24,691,246 |
Cashflow 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | · | $1M | |
| Stock-based Comp | $7M | $2M | $2M | $925.0K | $307.0K | $171.0K | $188.0K | $189.0K | $-57.0K | $-36.0K | $258.0K | $68.0K | $305.0K | $304.0K | $290.0K | $291.0K | |
| Deferred Tax | $0 | $-36.0K | $3M | $-48.0K | $-2M | $2M | $-546.0K | $18.0K | $110.0K | $-246.0K | $-400.0K | $29.0K | $-373.0K | $-377.0K | $36.0K | $-486.0K | |
| Operating Cash Flow | $1M | $7M | $7M | $14M | $-1M | $7M | $6M | $9M | $7M | $12M | $12M | $10M | $9M | $8M | $8M | $10M | |
| CapEx | $1M | $2M | $1M | $4M | $3M | $3M | $4M | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $2M | $4M | |
| Investing Cash Flow | $-1M | $-2M | $-1M | $-4M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-4M | $-4M | $-4M | $-3M | $-2M | $-4M | |
| Stock Repurchased | $8M | $2M | $1.0K | $9M | $6M | $5M | $7M | $9M | $0 | $15M | $15M | $309.0K | $2M | $2M | $2M | $3M | |
| Net Stock Activity | · | $-2M | · | · | · | $-5M | · | · | · | $-15M | · | · | · | $-2M | · | · | |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $28M | $3M | $3M | $6M | $6M | |
| Financing Cash Flow | $718.0K | $-7M | $-4M | $-13M | $7M | $-5M | $-1M | $-17.0K | $-3M | $-13M | $-5M | $-24M | $-6M | $-6M | $-10M | $-10M | |
| Net Change in Cash | $780.0K | $-2M | $2M | $-3M | $3M | $-2M | $772.0K | $3M | $-1M | $-5M | $3M | $-19M | $-1M | $-1M | $-3M | $-5M | |
| Taxes Paid | · | · | · | $373.0K | $3M | $80.0K | $2M | $2M | $4M | $78.0K | $2M | $2M | $4M | $27.0K | $3M | $3M | |
| Free Cash Flow | · | $5M | · | · | · | $4M | · | · | · | $8M | · | · | · | $5M | · | · | |
| Levered FCF | · | · | · | · | · | $3M | · | · | · | $7M | · | · | · | $4M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| Net Margin | -9.3% | 9.3% | · | 11.9% | -0.31% | 17.2% | · | 15.9% | 17.6% | 18.0% | · | 20.8% | 20.1% | 19.1% | · | 22.0% | |
| Pretax Margin | -12.8% | 12.6% | · | 18.1% | 1.7% | 23.0% | · | 20.4% | 23.8% | 23.2% | · | 26.5% | 26.1% | 24.7% | · | 28.8% | |
| EBITDA Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| ROA | -2.4% | 2.4% | · | 3.1% | -0.08% | 4.5% | · | 4.5% | 4.9% | 5.0% | · | 6.2% | 5.4% | 4.9% | · | 5.7% | |
| ROE | -23.5% | 14.9% | · | 16.9% | -0.34% | 17.4% | · | 12.3% | 10.5% | 11.4% | · | 12.5% | 9.9% | 8.9% | · | 11.0% | |
| ROIC | -2.3% | 4.5% | · | 5.4% | -0.28% | 7.0% | · | 7.5% | 9.0% | 9.4% | · | 12.5% | 8.8% | 8.8% | · | 11.8% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | · | 0.5 | 0.7 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 1.2 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 1.0 | 1.1 | · | 1.1 | |
| Debt / Equity | 14.4 | 5.8 | · | 5.6 | 3.8 | 2.1 | · | 1.4 | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 13.1 | 5.5 | · | 5.3 | 3.6 | 2.0 | · | 1.3 | 0.6 | 0.7 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 5.3 | 1.5 | 9.6 | · | · | · | 14.5 | · | 62.2 | 48.8 | 37.4 | · | 38.6 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 3.3 | 3.1 | · | 2.9 | 3.0 | 3.0 | · | 2.8 | 3.2 | 2.8 | · | 2.5 | 2.9 | 2.4 | · | 2.4 |
Bewertung (TTM) 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $139M | $137M | · | $138M | $138M | $140M | · | $144M | $144M | $146M | · | $148M | $148M | $150M | · | $151M | |
| Net Income TTM | $4M | $13M | · | $15M | $18M | $24M | · | $26M | $28M | $28M | · | $30M | $31M | $32M | · | $35M | |
| Market Cap | $478M | $383M | · | $290M | $388M | $292M | · | $537M | $548M | $946M | · | $1.09B | $1.07B | $1.07B | · | $983M | |
| Enterprise Value | $568M | $458M | · | $367M | $464M | $351M | · | $582M | $581M | $979M | · | $1.09B | $1.05B | $1.05B | · | $959M | |
| P/E | 134.8 | 30.3 | · | 19.4 | 22.7 | 12.5 | · | 21.0 | 20.1 | 34.1 | · | 36.4 | 35.4 | 34.0 | · | 28.8 | |
| P/S | 3.4 | 2.8 | · | 2.1 | 2.8 | 2.1 | · | 3.7 | 3.8 | 6.5 | · | 7.4 | 7.2 | 7.1 | · | 6.5 | |
| P/B | 72.9 | 28.4 | · | 20.2 | 18.2 | 9.8 | · | 15.5 | 13.6 | 25.6 | · | 18.8 | 13.7 | 14.3 | · | 14.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 73.2 | 93.3 | · | 218.3 | |
| P / Cash Flow | · | 53.3 | · | · | · | 43.9 | · | · | · | 78.6 | · | · | · | 138.1 | · | · | |
| P / FCF | · | 71.6 | · | · | · | 79.7 | · | · | · | 119.7 | · | · | · | 235.0 | · | · | |
| EV / EBITDA | -175.5 | 82.3 | · | 47.5 | 292.1 | 40.8 | · | 72.9 | 65.5 | 111.8 | · | 109.6 | 112.2 | 116.6 | · | 86.3 | |
| EV / FCF | · | 85.7 | · | · | · | 95.9 | · | · | · | 124.0 | · | · | · | 230.8 | · | · | |
| EV / Revenue | 4.1 | 3.3 | · | 2.7 | 3.4 | 2.5 | · | 4.0 | 4.0 | 6.7 | · | 7.4 | 7.1 | 7.0 | · | 6.3 | |
| Earnings Yield | 0.74% | 3.3% | · | 5.2% | 4.4% | 8.0% | · | 4.8% | 5.0% | 2.9% | · | 2.8% | 2.8% | 2.9% | · | 3.5% | |
| Payout Ratio | · | 112.5% | · | · | · | 47.9% | · | · | · | 45.7% | · | · | · | 42.4% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $137M | $143M | $149M | $152M | $148M |
| Betriebsgewinnmarge % | — | 24.6% | 27.0% | 30.7% | 34.0% |
| Nettoergebnis | $12M | $25M | $31M | $32M | $37M |
| Verwässerte EPS | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | 2.0 | 0.1 | 0.1 | 0.1 |
| Liquiditätsgrad | — | 0.5 | 0.7 | 1.3 | 1.8 |
| Quick Ratio | — | 0.4 | 0.5 | 1.2 | 1.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $19M | $22M | $26M | $41M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- US Nuclear Regulator Seeks Simpler Environmental Reviews To Boost Nuclear Expansion
- Die besten Aktien im Nuklearbereich, die Sie für Jahrzehnte kaufen und halten sollten
- In 10 Jahren, werden Sie es bereuen, NuScale Power Aktie nicht jetzt gekauft zu haben?
- Oklo im Vergleich zu NuScale Power: Beide fallen 2026, aber nur einer ist jetzt wertvoll zu kaufen
- New Jersey Gouverneurin Sherrill hebt 40-jährige Atomkraft-Moratorium auf
- Diese Atomenergie-Aktie für 10 US-Dollar könnte Ihr Ticket zum Millionärsstatus sein
- NuScale Power ist um 80 % gefallen -- das ist eine gute Nachricht für langfristige Anleger
- "Ein entscheidender Moment": Nano Nuclear reicht Baugenehmigung für Kronos-Reaktor in Illinois ein
- Oklo sichert sich eine NRC-Lizenz. Sollten Sie hier Aktien von OKLO kaufen?
- "Nachfrage nach kritischen Isotopen steigt, Angebot begrenzt": Oklo erhält erste NRC-Lizenz und weiteren DOE-Meilenstein
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 137 Einreicher · $161.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 23 (+8 vs. Vorquartal) | 11 (+2 vs. Vorquartal) | 39 (+15 vs. Vorquartal) | 36 (-21 vs. Vorquartal) | +719K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $27.842.578 | 1.290.801 | 17,27% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.377.570 | 666.554 | 8,92% | Aktien |
| VANGUARD GROUP INC | $13.753.511 | 732.739 | 8,53% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $9.997.975 | 463.513 | 6,20% | Aktien |
| Willis Investment Counsel | $9.378.312 | 434.785 | 5,82% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $8.039.557 | 372.614 | 4,99% | Aktien |
| FARMERS & MERCHANTS INVESTMENTS INC | $7.132.099 | 330.649 | 4,42% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.018.533 | 325.384 | 4,35% | Aktien |
| STATE STREET CORP | $6.483.381 | 298.384 | 4,02% | Aktien |
| HEARTLAND ADVISORS INC | $6.471.000 | 300.000 | 4,01% | Aktien |
| Bank of New York Mellon Corp | $4.964.788 | 230.171 | 3,08% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $4.053.434 | 187.920 | 2,51% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.562.120 | 118.782 | 1,59% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.444.140 | 113.312 | 1,52% | Aktien |
| Northwest & Ethical Investments L.P. | $2.208.121 | 102.370 | 1,37% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.096.604 | 97.200 | 1,30% | Aktien |
| JANE STREET GROUP, LLC | $1.881.918 | 87.247 | 1,17% | Aktien |
| FIFTH THIRD BANCORP | $1.841.475 | 85.372 | 1,14% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.762.808 | 81.725 | 1,09% | Aktien |
| COMERICA BANK | $1.687.723 | 89.916 | 1,05% | Aktien |
| Linden Thomas Advisory Services, LLC | $1.679.311 | 77.854 | 1,04% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.675.644 | 77.684 | 1,04% | Aktien |
| Quantinno Capital Management LP | $1.577.892 | 73.152 | 0,98% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.357.573 | 62.938 | 0,84% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $1.354.184 | 62.781 | 0,84% | Aktien |
| CITADEL ADVISORS LLC | $1.057.491 | 49.026 | 0,66% | Aktien |
| ALPS ADVISORS INC | $1.015.365 | 47.073 | 0,63% | Aktien |
| BlackRock, Inc. | $985.059 | 45.668 | 0,61% | Aktien |
| Williams Jones Wealth Management, LLC. | $901.626 | 41.800 | 0,56% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $831.847 | 38.565 | 0,52% | Aktien |
| Squarepoint Ops LLC | $798.112 | 37.001 | 0,50% | Aktien |
| GOLDMAN SACHS GROUP INC | $791.446 | 36.692 | 0,49% | Aktien |
| US BANCORP \DE\ | $675.637 | 31.323 | 0,42% | Aktien |
| HSBC HOLDINGS PLC | $634.793 | 29.539 | 0,39% | Aktien |
| Daiwa Securities Group Inc. | $629.218 | 29.171 | 0,39% | Aktien |
| MARSHALL WACE, LLP | $502.193 | 23.282 | 0,31% | Aktien |
| Empirical Finance, LLC | $431.400 | 20.000 | 0,27% | Aktien |
| Cove Street Capital, LLC | $417.063 | 32.634 | 0,26% | Aktien |
| OSAIC HOLDINGS, INC. | $389.338 | 18.050 | 0,24% | Aktien |
| AMERIPRISE FINANCIAL INC | $359.228 | 16.650 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $351.591 | 16.300 | 0,22% | Verkaufsoption |
| BANK OF AMERICA CORP /DE/ | $334.141 | 15.491 | 0,21% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $321.007 | 18.905 | 0,20% | Aktien |
| EXCHANGE TRADED CONCEPTS, LLC | $317.036 | 14.698 | 0,20% | Aktien |
| RHUMBLINE ADVISERS | $315.321 | 14.619 | 0,20% | Aktien |
| XTX Topco Ltd | $306.510 | 14.210 | 0,19% | Aktien |
| PCM Encore, LLC | $289.750 | 13.433 | 0,18% | Aktien |
| Empowered Funds, LLC | $284.681 | 13.198 | 0,18% | Aktien |
| MANGROVE PARTNERS IM, LLC | $284.616 | 13.195 | 0,18% | Aktien |
| IEQ CAPITAL, LLC | $282.735 | 13.108 | 0,18% | Aktien |
| R Squared Ltd | $265.052 | 12.288 | 0,16% | Aktien |
| Graham Capital Management, L.P. | $253.771 | 11.765 | 0,16% | Aktien |
| Vanguard Personalized Indexing Management, LLC | $248.659 | 11.528 | 0,15% | Aktien |
| WELLS FARGO & COMPANY/MN | $232.740 | 10.790 | 0,14% | Aktien |
| Vident Advisory, LLC | $230.907 | 10.705 | 0,14% | Aktien |
| TWO SIGMA ADVISERS, LP | $215.855 | 11.500 | 0,13% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $202.283 | 9.378 | 0,13% | Aktien |
| Aquatic Capital Management LLC | $187.810 | 8.707 | 0,12% | Aktien |
| DGS Capital Management, LLC | $176.100 | 10.371 | 0,11% | Aktien |
| BARCLAYS PLC | $166.693 | 7.728 | 0,10% | Aktien |
| MetLife Investment Management, LLC | $143.937 | 6.673 | 0,09% | Aktien |
| CWM, LLC | $130.440 | 7.682 | 0,08% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $117.470 | 5.446 | 0,07% | Aktien |
| Vanguard Global Advisers, LLC | $112.984 | 5.238 | 0,07% | Aktien |
| CITIGROUP INC | $104.787 | 4.858 | 0,06% | Aktien |
| Invesco Ltd. | $102.630 | 4.758 | 0,06% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $95.361 | 4.421 | 0,06% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $88.351 | 4.096 | 0,05% | Aktien |
| Copeland Capital Management, LLC | $77.997 | 3.616 | 0,05% | Aktien |
| Aviso Financial Inc. | $77.328 | 3.585 | 0,05% | Aktien |
| Russell Investments Group, Ltd. | $69.412 | 3.218 | 0,04% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $64.926 | 3.010 | 0,04% | Aktien |
| MEEDER ASSET MANAGEMENT INC | $62.208 | 2.884 | 0,04% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $53.602 | 2.484 | 0,03% | Aktien |
| FMR LLC | $48.619 | 2.254 | 0,03% | Aktien |
| Arax Advisory Partners | $48.425 | 2.245 | 0,03% | Aktien |
| NORTHERN TRUST CORP | $40.767 | 1.890 | 0,03% | Aktien |
| UBS Group AG | $38.395 | 1.780 | 0,02% | Aktien |
| Creative Planning | $31.018 | 1.438 | 0,02% | Aktien |
| Tower Research Capital LLC (TRC) | $30.133 | 1.397 | 0,02% | Aktien |
| HUNTINGTON NATIONAL BANK | $28.644 | 1.328 | 0,02% | Aktien |
| Legal & General Group Plc | $25.755 | 1.194 | 0,02% | Aktien |
| PNC Financial Services Group, Inc. | $25.151 | 1.166 | 0,02% | Aktien |
| GAMMA Investing LLC | $23.058 | 1.069 | 0,01% | Aktien |
| WealthCollab, LLC | $21.290 | 987 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $21.182 | 982 | 0,01% | Aktien |
| SIGNATUREFD, LLC | $20.642 | 957 | 0,01% | Aktien |
| Integrated Wealth Concepts LLC | $18.098 | 839 | 0,01% | Aktien |
| Pinnacle Wealth Planning Services, Inc. | $12.165 | 564 | 0,01% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $10.918 | 643 | 0,01% | Aktien |
| Nuveen, LLC | $9.642 | 447 | 0,01% | Aktien |
| EverSource Wealth Advisors, LLC | $9.167 | 425 | 0,01% | Aktien |
| IFP Advisors, Inc | $9.016 | 418 | 0,01% | Aktien |
| Parallel Advisors, LLC | $8.520 | 395 | 0,01% | Aktien |
| Farther Finance Advisors, LLC | $8.240 | 382 | 0,01% | Aktien |
| Lindbrook Capital, LLC | $8.166 | 638 | 0,01% | Aktien |
| QV Investors Inc. | $8.035 | 372.503 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $8.000 | 357 | 0,00% | Aktien |
| Versant Capital Management, Inc | $7.916 | 367 | 0,00% | Aktien |
| Nuveen Asset Management, LLC | $7.885 | 447 | 0,00% | Aktien |
Unternehmensinsider 27 Insider · 13 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Trent S Green | Chief Executive Officer | 1. Juni 2025 A | 500.000 | 0 | 0 | $0 |
| Shane R Harrison | EVP & Chief Financial Officer | 17. Februar 2026 P | 8.000 | 1 | 0 | $98.160 |
| Kevin R Karas | SVP Finance, CFO, Treas & Secy | 17. April 2018 D | 20.116 | 0 | 0 | $0 |
| Steven D. Jackson | President | 17. April 2018 D | 105.476 | 0 | 0 | $0 |
| Susan L Henricks | President and COO | 7. Januar 2014 A | 7.823 | 0 | 0 | $0 |
| Joseph W Carmichael | President | 9. Mai 2008 F | 41.872 | 0 | 0 | $0 |
| Helen Hrdy | EVP & Chief Operating Officer | 15. Dezember 2025 M | 140.518 | 0 | 0 | $0 |
| Jona S Raasch | COO, NRC Health | 3. April 2023 S | 1.688 | 0 | 0 | $0 |
| Jason Russell Rau | Executive Vice President | 12. März 2026 A | 60.000 | 0 | 0 | $0 |
| David Burik | EVP, Strategic Insights | 5. Januar 2026 A | 100.000 | 0 | 0 | $0 |
| Hays Michael D. | Chairman | 5. Januar 2026 M | 20.154 | 0 | 0 | $0 |
| Jordan Nicole Freeman | Chief Accounting Officer | 31. Juli 2025 P | 771 | 0 | 0 | $0 |
| Andrew Monnich | Chief Corp. Development Off. | 7. April 2025 A | 100.000 | 0 | 0 | $0 |
| Parul Bhandari | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| Penny Ann Wheeler | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| Stephen H Lockhart | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| Donald M Berwick | Direktor | 23. Juni 2026 A | 7.697 | 0 | 0 | $0 |
| John N Nunnelly | Direktor | 23. Juni 2026 A | 40.363 | 0 | 0 | $0 |
| Joann M Martin | Direktor | 17. April 2018 D | 218.455 | 0 | 0 | $0 |
| Barbara Mowry | Direktor | 17. April 2018 D | 6.902 | 0 | 0 | $0 |
| Gail L Warden | Direktor | 9. Mai 2017 A | 10.263 | 0 | 0 | $0 |
| Paul C Schorr III | Direktor | 28. Oktober 2013 G | 34.802 | 0 | 0 | $0 |
| Beans Patrick E. | 10%-Eigentümer | 12. Mai 2025 P | 35.003 | 0 | 0 | $0 |
| Common Property Trust | 10%-Eigentümer | 31. Dezember 2024 G | 4.755.317 | 0 | 0 | $0 |
| Amandla MK Trust | 10%-Eigentümer | 31. Dezember 2024 G | 0 | 0 | 0 | $0 |
| Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 | 10%-Eigentümer | 9. Juli 2018 S | 5.716.010 | 0 | 0 | $0 |
| Karen S Hays | 10%-Eigentümer | 12. Februar 2010 G | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Common Property Trust, Common Property Trust LLC, Amandla, LLC, Beans Patrick E., Hays Michael D. ×3 Einreichungen | 12. Juni 2026 | 45,70% | Änderung | — | SEC |
| Thomas Richardson, as the Trustee of Common Property Trust and as Manager of Common Property Trust LLC, Common Property Trust, Common Property Trust LLC ( ×2 Einreichungen | 5. März 2024 | — | Erste Einreichung | — | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the Amandla MK Trust, Amandla MK Trust ×9 Einreichungen | 4. Januar 2024 | — | Erste Einreichung | — | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the K/I/E Trust Under Agreement 10/24/18, K/I/E Trust Under Agreement 10/24/18 | 15. März 2021 | — | Erste Einreichung | — | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009), K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009) | 25. April 2018 | — | Erste Einreichung | — | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009, Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 | 14. Juni 2013 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 34 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| RFDA · ALPS ETF Trust | 1,07% | 48.034 NS | 31. Mai 2026 | N-PORT |
| DEEP · ETF Series Solutions | 1,00% | 13.384 NS | 31. Mai 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,33% | 11.133 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 39.841 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 15.935 NS | 31. Mai 2026 | N-PORT |
| SMLF · iShares Trust | 0,03% | 66.146 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 32.935 NS | 31. Mai 2026 | N-PORT |
| SFGV · EA Series Trust | 0,02% | 13.218 NS | 29. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 108.374 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 68.097 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.633 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 13.331 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 71.340 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 301.337 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 5.218 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 559 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 64.571 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 437 NS | 31. Mai 2026 | N-PORT |
| EBI · RBB Fund Trust | 0,00% | 993 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 444 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 560 NS | 30. April 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 476 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 468 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.921 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 11 NS | 31. Mai 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 4.055 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 17.485 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 23.454 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 11.000 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3.827 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 2.478 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 151.126 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 498.279 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 995 SH | 8. August 2026 | Täglich |